Lv519
870 积分 2024-07-23 加入
A Mnemonic for Management of Stable Chronic Obstructive Pulmonary Disease: A Canadian Approach
1个月前
已完结
Prevalence and Management of Chronic Obstructive Pulmonary Disease in the Gulf Countries with a Focus on Inhaled Pharmacotherapy
1个月前
已完结
Asthma management with triple ICS/LABA/LAMA combination to reduce the risk of exacerbation: an umbrella review compliant with the PRIOR statement
1个月前
已完结
Umeclidinium plus vilanterol versus fluticasone propionate plus salmeterol for chronic obstructive pulmonary disease: a meta-analysis of randomized, controlled trials
1个月前
已完结
Clinical Effectiveness and Safety of Dupilumab in Chronic Obstructive Pulmonary Disease Patients: A 7-Year Population-based Cohort Study
1个月前
已完结
Update on Newly FDA-Approved Drug, Resmetirom: A Practical Perspective
3个月前
已完结
LBP-045 Efficacy and safety of HSK31679, a thyroid hormone receptor β agonist, for the treatment of asian non-alcoholic fatty liver disease: a multicenter randomized, double-blind, placebo-controlled, phase 2a trial
3个月前
已完结
LBP-045 Efficacy and safety of HSK31679, a thyroid hormone receptor β agonist, for the treatment of asian non-alcoholic fatty liver disease: a multicenter randomized, double-blind, placebo-controlled, phase 2a trial
3个月前
已完结
Resmetirom proves positive for NASH with liver fibrosis
3个月前
已完结
Resmetirom for MASH-related cirrhosis
3个月前
已完结
皖公网安备34019202002308
